Our mission is to help solve investment managers’ evolving business and operational challenges through next-generation technology.
Enfusion is a global high-growth software-as-a-service (SaaS) provider focused on transforming the investment management industry. Our cloud-native solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better informed investment decisions in real time. We simplify investment and operational workflows.
We believe that we are the only solution that allows clients to see and interact with all parts of the investment management lifecycle, ranging from portfolio construction, trading, risk management, accounting and operations to investor reporting seamlessly in real time, in one screen, in one solution. As a result, our solution enables clients to better align teams, optimizing their investment decision-making, operations and technology footprint and lowering operating costs.
(Note: Enfusion priced its IPO at $17 – the top of its $15-to-$17 range – on 18.75 million shares, the number of shares in the prospectus, to raise $318.75 million.)
|Industry:||SERVICES - PREPACKAGED SOFTWARE|
|Address||125 South Clark Street, Suite 750 Chicago, IL 60603|
|Phone Number||(312) 253-9800|
|View Prospectus:||Enfusion, Inc.|
|Revenues||$93.25 mil (last 12 months)|
|Net Income||$1.75 mil (last 12 months)|
|Price range||$17.00 - $17.00|
|Est. $ Volume||$318.8 mil|
|Manager / Joint Managers||Morgan Stanley/ Goldman Sachs/ BofA Securities/ Credit Suisse|
|CO-Managers||Piper Sandler/ Stifel/ William Blair/ Loop Capital Markets|
|Expected To Trade:||10/21/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|